These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 7940952

  • 1. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM, Tu Y, Chou TC, Kahan BD.
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract] [Full Text] [Related]

  • 2. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.
    Ferraresso M, Knight R, Tu Y, Stepkowski SM, Kahan BD.
    Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953
    [No Abstract] [Full Text] [Related]

  • 3. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice.
    Tu Y, Stepkowski SM, Chou TC, Kahan BD.
    Transplantation; 1995 Jan 27; 59(2):177-83. PubMed ID: 7839437
    [Abstract] [Full Text] [Related]

  • 4. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
    Murphy MP, Morris RE.
    Transplant Proc; 1993 Jun 27; 25(3 Suppl 2):75-6. PubMed ID: 7685955
    [No Abstract] [Full Text] [Related]

  • 5. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Jun 27; 25(3 Suppl 2):29-31. PubMed ID: 8516939
    [No Abstract] [Full Text] [Related]

  • 6. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
    Hamashima T, Stepkowski SM, Smith S, Kahan BD.
    Transplant Proc; 1994 Oct 27; 26(5):3053-5. PubMed ID: 7940960
    [No Abstract] [Full Text] [Related]

  • 7. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
    Stepkowski SM, Kahan BD.
    Transplant Proc; 1991 Dec 27; 23(6):3262-4. PubMed ID: 1750091
    [No Abstract] [Full Text] [Related]

  • 8. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
    Wang M, Tu Y, Stepkowski SM, Kahan BD.
    Transplant Proc; 1993 Oct 27; 25(5):2876-7. PubMed ID: 8212271
    [No Abstract] [Full Text] [Related]

  • 9. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
    Morris RE, Wu J, Shorthouse R.
    Transplant Proc; 1990 Aug 27; 22(4):1638-41. PubMed ID: 1697111
    [No Abstract] [Full Text] [Related]

  • 10. Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.
    Morris RE, Meiser BM, Wu J, Shorthouse R, Wang J.
    Transplant Proc; 1991 Feb 27; 23(1 Pt 1):521-4. PubMed ID: 1703698
    [No Abstract] [Full Text] [Related]

  • 11. Combination therapy with Brequinar sodium and cyclosporine synergistically prolongs hamster-to-rat cardia xenograft survival.
    Cosenza CA, Cramer DV, Tuso PJ, Chapman FA, Wang HK, Makowka L.
    J Heart Lung Transplant; 1994 Feb 27; 13(3):489-97. PubMed ID: 8061026
    [Abstract] [Full Text] [Related]

  • 12. Concentration-controlled immunosuppressive regimens using cyclosporine with sirolimus or brequinar in human renal transplantation.
    Kahan BD.
    Transplant Proc; 1995 Feb 27; 27(1):33-6. PubMed ID: 7879019
    [No Abstract] [Full Text] [Related]

  • 13. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
    Hale DA, Gottschalk R, Wood ML, Maki T, Monaco AP.
    Transplant Proc; 1996 Dec 27; 28(6):3270-1. PubMed ID: 8962270
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
    Schmid C, Heemann U, Azuma H, Tilney NL.
    Transplant Proc; 1995 Feb 27; 27(1):438-9. PubMed ID: 7879053
    [No Abstract] [Full Text] [Related]

  • 15. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
    Cai Y, Tang XD, Zhou PJ.
    Scand J Immunol; 2005 Mar 27; 61(3):266-73. PubMed ID: 15787744
    [Abstract] [Full Text] [Related]

  • 16. Synergistic interaction of FTY720 with cyclosporine or sirolimus to prolong heart allograft survival.
    Stepkowski SM, Wang M, Qu X, Yu J, Okamoto M, Tejpal N, Kahan BD.
    Transplant Proc; 1998 Aug 27; 30(5):2214-6. PubMed ID: 9723445
    [No Abstract] [Full Text] [Related]

  • 17. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
    Chen H, Wu J, Luo H, Daloze P.
    Transplant Proc; 1992 Jun 27; 24(3):892-3. PubMed ID: 1604658
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the use of brequinar sodium and cyclosporine combination therapy for preventing rat cardiac allograft rejection.
    Cosenza CA, Cramer DV, Eiras-Hreha G, Cajulis E, Wang HK, Makowka L.
    Transplant Proc; 1993 Jun 27; 25(3 Suppl 2):57-8. PubMed ID: 8516945
    [No Abstract] [Full Text] [Related]

  • 19. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M, Antoniou E, DeRoover A, Nishimura Y, Howie A, McMaster P.
    Transplant Proc; 1996 Apr 27; 28(2):950-1. PubMed ID: 8623476
    [No Abstract] [Full Text] [Related]

  • 20. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
    Lin Y, Waer M.
    Transplant Proc; 1996 Dec 27; 28(6):3159. PubMed ID: 8962224
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.